Cancer Vaccine by Fusions of Dendritic and Cancer Cells
Open Access
- 1 January 2009
- journal article
- review article
- Published by Hindawi Limited in Journal of Immunology Research
- Vol. 2009, 1-13
Abstract
Dendritic cells (DCs) are potent antigen-presenting cells and play a central role in the initiation and regulation of primary immune responses. Therefore, their use for the active immunotherapy against cancers has been studied with considerable interest. The fusion of DCs with whole tumor cells represents in many ways an ideal approach to deliver, process, and subsequently present a broad array of tumor-associated antigens, including those yet to be unidentified, in the context of DCs-derived costimulatory molecules. DCs/tumor fusion vaccine stimulates potent antitumor immunity in the animal tumor models. In the human studies, T cells stimulated by DC/tumor fusion cells are effective in lysis of tumor cells that are used as the fusion partner. In the clinical trials, clinical and immunological responses were observed in patients with advanced stage of malignant tumors after being vaccinated with DC/tumor fusion cells, although the antitumor effect is not as vigorous as in the animal tumor models. This review summarizes recent advances in concepts and techniques that are providing new impulses to DCs/tumor fusions-based cancer vaccination.Keywords
This publication has 130 references indexed in Scilit:
- Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodiesJournal of Experimental Medicine, 2009
- TGF-β Promotes Th17 Cell Development through Inhibition of SOCS3The Journal of Immunology, 2009
- In vitro generation of cytotoxic and regulatory T cells by fusions of human dendritic cells and hepatocellular carcinoma cellsJournal of Translational Medicine, 2008
- Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3 + CD4 + regulatory T cellsProceedings of the National Academy of Sciences, 2008
- Dendritic Cell-Ewing’s Sarcoma Cell Hybrids Enhance Antitumor ImmunityClinical Orthopaedics and Related Research, 2008
- Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccinesCancer Immunology, Immunotherapy, 2008
- Whole tumor antigen vaccination using dendritic cells: Comparison of RNA electroporation and pulsing with UV-irradiated tumor cellsJournal of Translational Medicine, 2008
- DC-based cancer vaccinesJournal of Clinical Investigation, 2007
- Generation and functional assessment of antigen-specific T cells stimulated by fusions of dendritic cells and allogeneic breast cancer cellsVaccine, 2007
- Regulatory T cells, tumour immunity and immunotherapyNature Reviews Immunology, 2006